Connection

Dariusz Pytel to Doxorubicin

Back to Details
This is a "connection" page, showing publications Dariusz Pytel has written about Doxorubicin.
Dariusz Pytel
Connection Strength
0.062
Doxorubicin
  1. Imatinib mesylate (STI571) abrogates the resistance to doxorubicin in human K562 chronic myeloid leukemia cells by inhibition of BCR/ABL kinase-mediated DNA repair. Mutat Res. 2006 Jan 31; 603(1):74-82.
    View in: PubMed
    Score: 0.062
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.